
GLP-1 Regain Risk: Why Weight Loss Benefits Fade Fast After Stopping
A significant new meta-analysis highlights a critical challenge for individuals using GLP-1 medications like Semaglutide and Tirzepatide: rapid weight regain upon cessation. Researchers suggest obesity requires chronic management, similar to other long-term conditions.







